I'm a bit torn with this one.I agree with @downtoearth (that's a first). Revenue is not there at all, acquiring a company to list is also dodgy.What do you like about it @stardestr0yer
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution